C25H30N6O3
462.5 g/mol
APIDanger
Vistusertib
CAS1009298-59-2
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Vistusertib is an active pharmaceutical ingredient being investigated for use in research. It functions as a potent and selective dual inhibitor of mTORC1 and mTORC2.
research compound for advanced gastric adenocarcinoma studiesdual mTORC1/mTORC2 inhibitor in laboratory research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1009298-59-2
Related Compounds
ReferenceSame Category
Levofloxacin
CAS100986-85-4
pharmaceutical raw material
ReferenceSame Category
Pyridostigmine bromide
CAS101-26-8
pharmaceutical raw material
ReferenceSame Category
Hyoscyamine
CAS101-31-5
pharmaceutical raw material
ReferenceSame Category
2-methyl-5-nitroimidazol-1-ylacetic acid
CAS1010-93-1
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H360May damage fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide
InChIKey
JUSFANSTBFGBAF-IRXDYDNUSA-N
SMILES
C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOC[C@@H]5C
Synonyms (13)
- EX-A155
- Vistusertib (JAN/INN)
- AZD 2014
- AZD2014; Vistusertib
- SDCCGSBI-0654471.P001
- Vistusertib
- Vistusertib (AZD-2014)
- vistusertibum